Awareness of cytomegalovirus and risk factors for susceptibility among pregnant women, in Montreal, Canada

BMC Pregnancy and Childbirth

Volumn 16, Issue 1, 2016, Pages

  Wizman, Sarah ^a,c   Lamarre, Valérie ^a   Coic, Lena ^a   Kakkar, Fatima ^a   Le Meur, Jean Baptiste ^b   Rousseau, Céline ^a   Boucher, Marc ^a   Tapiero, Bruce ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c CHU Sainte Justine ^*  (Canada)

Author keywords

Awareness; Cytomegalovirus; Pregnant women; Serostatus; Socio demographic risk factors

Indexed keywords

IMMUNOGLOBULIN G;

ADULT; ARTICLE; ATTITUDE TO HEALTH; BIRTHPLACE; BLOOD ANALYSIS; CANADA; CONTROLLED STUDY; COUNSELING; CYTOMEGALOVIRUS INFECTION; EMPLOYMENT STATUS; FEMALE; FIRST TRIMESTER PREGNANCY; HEALTH EDUCATION; HUMAN; INFECTION RISK; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; PREGNANT WOMAN; PREVALENCE; PRIMARY INFECTION; QUESTIONNAIRE; ADOLESCENT; BLOOD; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PSYCHOLOGY; QUEBEC; RISK FACTOR; SEROEPIDEMIOLOGY; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; IMMUNOGLOBULIN G; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY TRIMESTER, FIRST; PREGNANT WOMEN; QUEBEC; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; YOUNG ADULT;

EID: 84960933370     PISSN: None     EISSN: 14712393     Source Type: Journal    
DOI: 10.1186/s12884-016-0844-9     Document Type: Article

References (44)

1. Kenneson A, Cannon MJ. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol. 2007;17(4):253-76.
2. Grosse SD, Ross DS, Dollard SC. Congenital cytomegalovirus (CMV) infection as a cause of permanent bilateral hearing loss: a quantitative assessment. J Clin Virol. 2008;41(2):57-62. Epub 2007/10/26.
3. Dollard SC, Grosse SD, Ross DS. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol. 2007;17(5):355-63.
4. Yow MD, Demmler GJ. Congenital cytomegalovirus disease - 20years is long enough. N Engl J Med. 1992;326(10):702-3.
5. Grosse SD, Ortega-Sanchez IR, Bialek SR, Dollard SC. The economic Impact of Congenital CMV Infection: Methods and Estimates In: Reddehase MJ, editor. Cytomegalovirus: from Molecular Pathogenesis to Intervention. Germany: Caister Academic Press; 2013: p49-55.
6. Lopez AS, Ortega-Sanchez IR, Bialek SR. Congenital Cytomegalovirus-related Hospitalizations in infants <1 Year of Age, United States, 1997-2009. PIDJ. 2014;33(11):1119-23.
7. Stagno S, Pass RF, Dworsky ME, Henderson RE, Moore EG, Walton PD, et al. Congenital cytomegalovirus infection: the relative importance of primary and recurrent maternal infection. NEJM. 1982;306(16):945-9.
8. Fowler KB, Stagno S, Pass RF, Britt WJ, Boll TJ, Alford CA. The outcome of congenital infection in relation to maternal antibody status. NEJM. 1992;326:663-7.
9. Boppana SB, Rivera LB, Fowler KB, et al. Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity. NEJM. 2001;344(18):1366-71.
10. Carlson A, Norwitz E, Stiller RJ. Cytomegalovirus infection in pregnancy: should all women be screened? Rev Obst Gynecol. 2010;3(4):172-9.
11. Walker S, Palma-Dias R, Wood EM, Shekleton P, Giles ML. Cytomeglaovirus in pregnancy: to screen or not to screen. BMC Pregnancy Childbirth. 2013;13:96.
12. Boppana SB et al. Saliva polymerase-chain-reaction assay for cytomegalovirus screening in newborns. N Engl J Med. 2011;364(22):2111-8.
13. Oliver SE et al. Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system. J Clin Virol. 2009;46 Suppl 4:S22-6.
14. Kimberlin DW et al. Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J Pediatr. 2003;143(1):16-25.
15. Kimberlin DW et al. Pharmacokinetic and pharmacodynamic assessment of oral valganciclovir in the treatment of symptomatic congenital cytomegalovirus disease. J Infect Dis. 2008;197(6):836-45.
16. Kimberlin, D.W. Six months versus six weeks of oral valganciclovir for infants with symptomatic congenital cytomegalovirus (CMV) disease with and without central nervous system involvement: Results of a Phase III, randomized, double- blind, placebo-controlled, multinational study.ID week, october 5, 2013.
17. Kimberlin et al. Valgancyclovir for symptomatic congenital cytomegalovirus. NEJM. 2015;372(10):933-43.
18. Manicklal S, Emery VC, Lazzarotto T, Boppana SB, Gupta RK. The "silent" global burden of congenital cytomegalovirus. Clin Microbiol Rev. 2013;26(1):86-102.
19. Adler SP, Finney JW, Manganello AM, Best AM. Prevention of child-to mother transmission of cytomegalovirus among pregnant women. J Pediatr. 2004;145:485-91.
20. Harvey J, Dennis CL. Hygiene interventions for prevention of cytomegalovirus infection among childbearing women: systematic review. J Adv Nurs. 2008;63(5):440-50.
21. Vauloup-Fellous C, Picone O, Cordier AG, Parent-du-Chatelet I, Senat MN, Frydman R, Grangeot-Keros L: Does hygiene counseling have an impact on the rate of CMV primary infection during pregnancy? Results of a 3 year prospective study in a French Hospital. J Clin Virol. 2009;46 suppl 4:S 49-53.
22. Embil JA et al. Prevalence of cytomegalovirus infection in a normal urban population in Nova Scotia. Can Med Assoc J. 1969;101(12):78-81.
23. Embil JA, Macdonald JM, Scott KE. Survey of a neonatal population for the prevalence of cytomegalovirus. Scand J Infect Dis. 1975;7(3):165-7.
24. Larke RP et al. Congenital cytomegalovirus infection in an urban Canadian community. J Infect Dis. 1980;142(5):647-53.
25. Montplaisir S, Martineau B. Infection caused by the cytomegalic virus (CMV) in the area of Montreal: an epidemiologic study. Can J Public Health. 1972;63(4):333-41.
26. Preiksaitis JK, Larke RP, Froese GJ. Seroepidemiology of cytomegalovirus infection in the Northwest Territories of Canada. Arctic Med Res. 1988;47 Suppl 1:701-4.
27. Joseph SA et al. Risk factors for cytomegalovirus seropositivity in a population of day care educators in Montreal, Canada. Occup Med (Lond). 2005;55(7):564-7.
28. Vaudry W et al. Congenital cytomegalovirus infection in high-risk Canadian infants: Report of a pilot screening study. Can J Infect Dis Med Microbiol. 2010;21(1):e12-9.
29. Comeau M. Messier M, Lavoie S. Caracteristiques des mères de nouveaux-nés à Montréal. L'evolution des naissances à Montréal, 1984-2009. Bibliothèque et Archives nationales du Quebec et Canada, 2011.
30. Stadler LP, Bernstein DI, Callahan ST, Turley CB, Munoz FM, Ferreira J, Achaya M, Simone AG, Patel SM, Edwards KM, Rosenthal SL. Seroprevalence and Risk Factors for Cytomegalovirus Infections in Adolescent Females. JPIDS. 2013;2(1):7-14.
31. Canada S. Income Statistics Division, Annual Income Estimates for Census Families and Individuals. 2014.
32. Basha J et al. Congenital cytomegalovirus infection is associated with high maternal socio-economic status and corresponding low maternal cytomegalovirus seropositivity. J Paediatr Child Health. 2014;50(5):368-72.
33. Stars SA et al. Seroprevalence of cytomegalovirus infection in the United States, 1988-1994. CID. 2006;43:1143-51.
34. Adler SP. Molecular epidemiology of cytomegalovirus: viral transmission among children attending a daycare center, their parents, and caretakers. J Pediatr. 1988;112(3):366-72.
35. Statistics Canada. Report of the Pan - Canadian Education Indicators Program. 2014.
36. Statistics Canada. Canadian Council on Social Development Stats and Facts, Report. 2012.
37. Ford-Jones EL, Kitai I, Davis L, Corey M, Farrell H, Petric M, et al. Cytomegalovirus infection in Toronto child-care centers: a prospective study of viral excretion in children and seroconversion among day-care providers. Pediatr Infect Dis J. 1996;15:507-14.
38. Ross DS et al. Women's knowledge of congenital cytomegalovirus: results from the 2005 HealthStyles survey. J Womens Health (Larchmt). 2008;17(5):849-58.
39. Price SM, Bonilla E, Zador P, Levis DM, Kilgo CL, Cannon MJ. Educating women about congenital Cytomegalovirus: assessment of health education material through a web-based survey. BMC Womens Health. 2014;14:144.
40. Pereboom MT et al. Observational study to assess pregnant women's knowledge and behaviour to prevent toxoplasmosis, listeriosis and cytomegalovirus. BMC Pregnancy Childbirth. 2013;13:98.
41. Adler S, Finney J, Manganello AM, Best A. Prevention of child-to-mother transmission of cytomegalovirus among pregnant women. J Ped. 2004;145:485-91.
42. American College of Obstetrics and Gynecologists. ACOG practice bulletin. Perinatal viral and parasitic infections. Number 20, September 2000. Int J Gynaecol Obstet. 2002;76:95-107.
43. Centers for Disease Control and Prevention. Knowledge and practices of obstetricians and gynecologists regarding cytomegalovirus infection during pregnancy-United States, 2007. MMWR. 2008;57(3):65-8.
44. Statistic Canada. Proportion of foreign born population and population belonging to visible minority groups per metropolitan census area, 2006 and projection 2031. National Household Survey, July 2011, p8. www12.statcan.gc.ca.